Saturday, October 3, 2026

Articles by Country

December 24, 2018

Argentina

Bangladesh

Belgium

Brazil

Colombia

China

Dominican Republic

Egypt

Equador

Ethiopia

Haiti

Panama

Philippines

France

Georgia

Germany

Greece

India

Indonesia

Israel

Italy

Kenya

North korea

Myanmar

Nigeria

Norway

Pakistan

Portugal

Romania

Russia

Rwanda

Saudi Arabia

Scotland

Serbia

South Africa

Spain

South Sudan

Switzerland

Turkey

Ukraine

United Kingdom

United States of America

Uruguay

Venezuela

Categories

Uncategorized

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts

AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.

Our read on the data ›

Signals we're tracking

Satellite-Terrestrial Network Integration Acceleration

Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases

Patterns we're watching ›

Where sources disagree

Apple Inc.

The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,985

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,985 facts checked against source5,327 source documents archived

Query this data → isubstrate.com